ロード中…
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...
| 主要な著者: | , , |
|---|---|
| フォーマット: | Online 論文 テキスト |
| 言語: | English |
| 出版事項: |
Dove Medical Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918234/ https://www.ncbi.nlm.nih.gov/pubmed/27471700 http://dx.doi.org/10.2147/ITT.S40121 |